Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Palisade Bio Inc (NASDAQ: PALI) closed the day trading at $0.79 down -10.05% from the previous closing price of $0.88. In other words, the price has decreased by -$10.05 from its previous closing price. On the day, 2.83 million shares were traded. PALI stock price reached its highest trading level at $0.8606 during the session, while it also had its lowest trading level at $0.771.
Ratios:
For a better understanding of PALI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.81 and its Current Ratio is at 2.81. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PALI now has a Market Capitalization of 3947063 and an Enterprise Value of -3392960.
Stock Price History:
The Beta on a monthly basis for PALI is 1.43, which has changed by -0.784153 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, PALI has reached a high of $4.32, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is -1.93%, while the 200-Day Moving Average is calculated to be -39.19%.
Shares Statistics:
Over the past 3-months, PALI traded about 2.14M shares per day on average, while over the past 10 days, PALI traded about 10348840 shares per day. A total of 4.80M shares are outstanding, with a floating share count of 4.76M. Insiders hold about 0.81% of the company’s shares, while institutions hold 5.43% stake in the company. Shares short for PALI as of 1752537600 were 813858 with a Short Ratio of 0.38, compared to 1749772800 on 1116795. Therefore, it implies a Short% of Shares Outstanding of 813858 and a Short% of Float of 17.05.
Earnings Estimates
The dynamic stock of Palisade Bio Inc (PALI) is currently being evaluated by a team of 3.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.17 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.01 and -$1.92 for the fiscal current year, implying an average EPS of -$1.57. EPS for the following year is -$1.21, with 3.0 analysts recommending between -$0.6 and -$1.77.
